QuidelOrtho CorporationQDELNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-0.3%
5Y CAGR+17.2%
Year-over-Year Change
Research and development spending
3Y CAGR
-0.3%/yr
vs +38.1%/yr prior
5Y CAGR
+17.2%/yr
Recent deceleration
Acceleration
-38.4pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $186.20M | -14.9% |
| 2024 | $218.70M | -11.4% |
| 2023 | $246.80M | +31.3% |
| 2022 | $187.90M | +96.3% |
| 2021 | $95.70M | +13.5% |
| 2020 | $84.29M | +60.4% |
| 2019 | $52.55M | +1.8% |
| 2018 | $51.65M | +53.5% |
| 2017 | $33.64M | -13.0% |
| 2016 | $38.67M | - |